193 related articles for article (PubMed ID: 12582407)
1. Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy.
Mallbris L; Ljungberg A; Hedblad MA; Larsson P; Ståhle-Bäckdahl M
J Am Acad Dermatol; 2003 Feb; 48(2):290-3. PubMed ID: 12582407
[TBL] [Abstract][Full Text] [Related]
2. Recalcitrant cutaneous sarcoidosis responding to adalimumab but not to etanercept.
Field S; Regan AO; Sheahan K; Collins P
Clin Exp Dermatol; 2010 Oct; 35(7):795-6. PubMed ID: 20831604
[No Abstract] [Full Text] [Related]
3. Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases.
Heidelberger V; Ingen-Housz-Oro S; Marquet A; Mahevas M; Bessis D; Bouillet L; Caux F; Chapelon-Abric C; Debarbieux S; Delaporte E; Duval-Modeste AB; Fain O; Joly P; Marchand-Adam S; Monfort JB; Noël N; Passeron T; Ruivard M; Sarrot-Reynauld F; Verrot D; Bouvry D; Fardet L; Chosidow O; Sève P; Valeyre D
JAMA Dermatol; 2017 Jul; 153(7):681-685. PubMed ID: 28564695
[TBL] [Abstract][Full Text] [Related]
4. Infliximab as a steroid-sparing agent in refractory cutaneous sarcoidosis: single-center retrospective study of 9 patients.
Sené T; Juillard C; Rybojad M; Cordoliani F; Lebbé C; Morel P; Tazi A; Guibal F
J Am Acad Dermatol; 2012 Feb; 66(2):328-32. PubMed ID: 22243729
[No Abstract] [Full Text] [Related]
5. Refractory sarcoidosis responding to infliximab.
Roberts SD; Wilkes DS; Burgett RA; Knox KS
Chest; 2003 Nov; 124(5):2028-31. PubMed ID: 14605086
[TBL] [Abstract][Full Text] [Related]
6. Successful long-term management of refractory cutaneous and upper airway sarcoidosis with periodic infliximab infusion.
Rosen T; Doherty C
Dermatol Online J; 2007 Jul; 13(3):14. PubMed ID: 18328208
[TBL] [Abstract][Full Text] [Related]
7. Infliximab therapy for sarcoidosis (lupus pernio).
Haley H; Cantrell W; Smith K
Br J Dermatol; 2004 Jan; 150(1):146-9. PubMed ID: 14746631
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous sarcoidosis and infliximab: evidence for efficacy in refractory disease.
Tu J; Chan J
Australas J Dermatol; 2014 Nov; 55(4):279-81. PubMed ID: 23651297
[TBL] [Abstract][Full Text] [Related]
9. Refractory chronic cutaneous sarcoidosis responsive to dose escalation of TNF-alpha antagonists.
Thielen AM; Barde C; Saurat JH; Laffitte E
Dermatology; 2009; 219(1):59-62. PubMed ID: 19468200
[TBL] [Abstract][Full Text] [Related]
10. Infliximab in dermatological treatment: beyond psoriasis.
Rigopoulos D; Korfitis C; Gregoriou S; Katsambas AD
Expert Opin Biol Ther; 2008 Jan; 8(1):123-33. PubMed ID: 18081542
[TBL] [Abstract][Full Text] [Related]
11. Ulcerative cutaneous sarcoidosis responding to adalimumab.
Philips MA; Lynch J; Azmi FH
J Am Acad Dermatol; 2005 Nov; 53(5):917. PubMed ID: 16243166
[No Abstract] [Full Text] [Related]
12. A review of the use of infliximab to manage cutaneous dermatoses.
Gupta AK; Skinner AR
J Cutan Med Surg; 2004; 8(2):77-89. PubMed ID: 15685387
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous tuberculosis revealed by infliximab therapy for presumed sarcoidosis.
Fraser SJ; Hill AT; McKay DA; Reid WA; Mathers ME; MacDougall G; Schofield OM
Clin Exp Dermatol; 2010 Jun; 35(4):e141-2. PubMed ID: 19886968
[No Abstract] [Full Text] [Related]
14. Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis.
Sweiss NJ; Welsch MJ; Curran JJ; Ellman MH
Arthritis Rheum; 2005 Oct; 53(5):788-91. PubMed ID: 16208666
[No Abstract] [Full Text] [Related]
15. Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses.
Drosou A; Kirsner RS; Welsh E; Sullivan TP; Kerdel FA
J Cutan Med Surg; 2003; 7(5):382-6. PubMed ID: 14973643
[TBL] [Abstract][Full Text] [Related]
16. The use of infliximab in cutaneous sarcoidosis.
Meyerle JH; Shorr A
J Drugs Dermatol; 2003 Aug; 2(4):413-4. PubMed ID: 12884466
[TBL] [Abstract][Full Text] [Related]
17. Case series demonstrating improvement in chronic cutaneous sarcoidosis following treatment with TNF inhibitors.
Wanat KA; Rosenbach M
Arch Dermatol; 2012 Sep; 148(9):1097-100. PubMed ID: 22986883
[No Abstract] [Full Text] [Related]
18. Cutaneous sarcoidosis.
Marchell RM; Judson MA
Semin Respir Crit Care Med; 2010 Aug; 31(4):442-51. PubMed ID: 20665394
[TBL] [Abstract][Full Text] [Related]
19. Adalimumab for treatment of cutaneous sarcoidosis.
Heffernan MP; Smith DI
Arch Dermatol; 2006 Jan; 142(1):17-9. PubMed ID: 16415380
[No Abstract] [Full Text] [Related]
20. Tumor necrosis factor alpha inhibitors for the treatment of dermatologic diseases.
Trent JT; Kerdel FA
Dermatol Nurs; 2005 Apr; 17(2):97-107. PubMed ID: 15916184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
